The Biomolecules and Biomedicine (formerly, the Bosnian Journal of Basic Medical Sciences, BJBMS) is а premier venue for discoveries in basic and clinical biomedical science. The BJBMS was founded in 1998 and is published by the Association of Basic Medical Sciences, a nonprofit honor organization of physician-scientists.

Broad readership and scope. The BiomolBiomed reaches readers across a wide range of medical disciplines and sectors. The journal publishes basic and translational/clinical research submissions and reviews in all biomedical specialties, including Genetics and Molecular Biology, Immunology, Microbiology, Pathology, Biochemistry, Pharmacology, Anatomy, Biomaterials, New and Emerging Research and Diagnostic Methods, New and Emerging Medical Entities, and others.

Open access. All research is available to the public for free. The BiomolBiomed deposits published articles in PubMed Central, which satisfies the NIH Public Access Policy and other similar funding agency requirements.

Editorial Board. Renowned international experts in the journal’s Editorial Board, together with external peer-reviewers select the best of the submissions for publication.

Celebrating Latest Achievements at Biomolbiomed Journal
Sources: PubMed Central, Journal Citation Reports (Clarivate Analytics), Google Scholar, CiteScore (Scopus)

High visibility

  • Open Access: articles are freely available to readers immediately after publication.
  • Highly accessed online content: more than 350,000 readers/month (100,000 at PubMed Central (April 2024); 120,000 at Journal’s website (April 2024); more than 130,000 at Web of Science, Scopus, Google Scholar, and others).
  • Newsletters: more than 20,000 registered users receive a newsletter tailored to their field of interest.
  • Social media: articles are promoted through various social media channels (TwitterLinkedInFacebook)
  • Advanced online: all accepted articles are published Advanced online and Ahead of print on PubMed within 3 days of acceptance, with citable DOIs, to make the article accessible as fast as possible.
  • Print circulation: 200 copies of print issues are sent to major libraries, institutes, universities, conferences, and subscribers across the globe. Get the free sample copy here.
  • BiomolBiomed Viewpoints: Journal’s blog that promotes authors and their research by publishing plain language summaries for wide audience and media, as well as commentaries, interviews, news and stories related to science and research.

Indexing and abstracting

Timely publication

  • Time to First Editorial Decision (Rejection or Peer Review): 2 days
  • Time to First Decision after review (Rejection or Revision or Acceptance): 22 days
  • Time from Acceptance to Publication: 1 day (if no significant language editing is required)
  • Rejections without peer review: 40%
  • Acceptance Rate: 25%

Meaningful metrics

The success of the articles published in BiomolBiomed is tracked in real-time by individualized Article-Level Metrics (Dimensions and PlumX). These reflect the viewership, download rates, social sharing, citations, field citation ratio, and relative citation ratio for each published article in a real-time, and help you illustrate the impact of your research

Journal Impact Factor® (JCR/Clarivate Analytics):

  • 2023 = 3.1
  • 2022 = 3.4
  • 2021 = 3.759
  • 2019 = 2.050
  • 2018 = 1.458
  • 2017 = 1.432
  • 2016 = 0.906
  • 2015 = 0.652
  • 2014 = 0.443

CiteScore® (SCOPUS/Elsevier)

  • 2023 = 7.4 Check the latest CiteScore
  • 2022 = 5.3
  • 2021 = 5.2
  • 2019 = 3.20
  • 2018 = 1.43
  • 2017 = 1.31
  • 2016 = 0.94
  • 2015 = 0.78
  • 2014 = 0.59

BiomolBiomed Viewpoints:

  • Publishes non-technical author’s summaries for media and wide non-expert audience to promote the author’s findings and research
  • Publishes interviews with experts
  • Publishes commentaries